Canada markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
289.74+13.27 (+4.80%)
At close: 03:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 18.08B
Enterprise Value 13.98B
Trailing P/E 24.29
Forward P/E 25.91
PEG Ratio (5 yr expected) 1.25
Price/Sales (ttm)7.47
Price/Book (mrq)4.01
Enterprise Value/Revenue 0.79
Enterprise Value/EBITDA 1.96

Trading Information

Stock Price History

Beta (5Y Monthly) 0.78
52-Week Change 3-31.69%
S&P500 52-Week Change 322.38%
52 Week High 3426.50
52 Week Low 3262.00
50-Day Moving Average 3291.29
200-Day Moving Average 3320.54

Share Statistics

Avg Vol (3 month) 31k
Avg Vol (10 day) 3890
Shares Outstanding 564.66M
Implied Shares Outstanding 666.17M
Float 864.48M
% Held by Insiders 10.01%
% Held by Institutions 147.75%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in DKK.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 30.74%
Operating Margin (ttm)19.33%

Management Effectiveness

Return on Assets (ttm)10.63%
Return on Equity (ttm)18.32%

Income Statement

Revenue (ttm)17.78B
Revenue Per Share (ttm)272.41
Quarterly Revenue Growth (yoy)45.20%
Gross Profit (ttm)N/A
EBITDA 5.95B
Net Income Avi to Common (ttm)5.47B
Diluted EPS (ttm)11.94
Quarterly Earnings Growth (yoy)486.30%

Balance Sheet

Total Cash (mrq)29.58B
Total Cash Per Share (mrq)454.15
Total Debt (mrq)1.01B
Total Debt/Equity (mrq)3.11%
Current Ratio (mrq)12.46
Book Value Per Share (mrq)498.87

Cash Flow Statement

Operating Cash Flow (ttm)5.66B
Levered Free Cash Flow (ttm)3.83B